The Bayer-Cipla, patent-drug regulatory linkage case which was scheduled to be heard on the 3rd of August, 2010 has now been batted away to the 30th of November, 2010. In the highest traditions of the Bar, one lawyer asked for an adjournment, while the other graciously consented to the same.
Earlier on the 13th of April, 2010 the pertinent part of the Supreme Court Order read as follows:
The parties are in agreement that the matter may be adjourned to August 3, 2010, and on that date it may be heard for final disposal.
The pertinent part of the Supreme Court Order on the 3rd of August, 2010 reads as follows:
Dr. A.M. Singhvi makes a prayer for adjournment with the consent of Mr. Shanti Bhushan, learned senior counsel appearing for the petitioner.
The parties are in agreement that this case may be fixed on a non-miscellaneous day in the week commencing November 29, 2010.
Let this matter come in that week.
We’ll keep you posted on the future of this case.
In the words of Sunny Deol,
Tarikh pe tarikh…[]..
Even the senior lawyers are resorting to these tactics. Wonder what the clients have to say about this…
What else you can expect from Indian Judiciary???
I think they all the parties in the case, including the court, are seeking to balance their position, since the issue involved is veru critical for the future of generic drugs in India.
Mohit